Safety and Efficacy of Two Year of RAAS Alone or in Combination With Spironolactone Therapy
Clinical trial NCT03502031 · UNKNOWN
Trial details
- NCT number
- NCT03502031
- Sponsor
- James A. Tumlin, MD
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2022-10-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.